ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Iowa » Internal Medicine

Top Internal Medicine Prescribers in Iowa

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOHN RASHID MD

Internal Medicine

13,673

$633K

454
374 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $50

MICHAEL MANKARIOUS M.D.

Internal Medicine

13,497

$684K

380
278 are 65+

23%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $50

KENNETH LYONS M.D.

Internal Medicine

13,456

$634K

550
519 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $50

PRATIBHA DUA MD

Internal Medicine

13,382

$595K

465
402 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $50

DOUGLAS JERGENSON MD

Internal Medicine

13,332

$768K

698
623 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $50

JOSEPH MILLER D.O.

Internal Medicine

13,314

$601K

317
256 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

21%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $50

JASHIM AHMED MD

Internal Medicine

13,205

$697K

635
447 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $50

REY LIN MD

Internal Medicine

13,106

$610K

376
324 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $50

RODNEY ZEITLER M.D.

Internal Medicine

13,013

$463K

476
448 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$36
Average prescription price

Avg: $50

MARK RUNDE M.D.

Internal Medicine

12,953

$474K

606
534 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$37
Average prescription price

Avg: $50

MATTHEW FRYZEK M.D.

Internal Medicine

12,940

$738K

397
282 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $50

CURTIS HESSE D.O.

Internal Medicine

12,642

$591K

363
322 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $50

JAMES NORDSTROM MD

Internal Medicine

12,599

$539K

526
502 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$43
Average prescription price

Avg: $50

ALFRED SAVAGE D.O.

Internal Medicine

12,591

$411K

354
304 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 11%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$33
Average prescription price

Avg: $50

LAZARO RABANG MD

Internal Medicine

12,335

$747K

607
528 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $50

JOHN IPPOLITO M.D.

Internal Medicine

12,281

$567K

265
222 are 65+

15%
patients receiving schedule two controlled substances

Avg: 5%

32%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $50

RICHARD PETERS MD

Internal Medicine

12,092

$445K

342
310 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$37
Average prescription price

Avg: $50

THOMAS YOUNG D.O.

Internal Medicine

11,948

$419K

381
328 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

19%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$35
Average prescription price

Avg: $50

MELANIE STAHLBERG MD

Internal Medicine

11,946

$545K

565
497 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $50

ROBERT BLOMMER MD

Internal Medicine

11,907

$452K

605
499 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$38
Average prescription price

Avg: $50

MICHAEL GOMENDOZA MD

Internal Medicine

11,798

$751K

442
365 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $50

STANLEY BLEW MD

Internal Medicine

11,756

$375K

514
441 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$32
Average prescription price

Avg: $50

VINAY SATTI MD

Internal Medicine

11,701

$474K

672
297 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$41
Average prescription price

Avg: $50

LEATRICE OLSON DO

Internal Medicine

11,644

$718K

451
313 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

21%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $50

MARK MOORE M.D.

Internal Medicine

11,641

$478K

585
525 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$41
Average prescription price

Avg: $50

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank